Ergomed Group provides specialized services to the biotech and pharmaceutical industry, including full-service pharmacovigilance and clinical trial solutions.

Ergomed Group

AHRM is a specialty CRO that focuses on Health Economics and Outcomes Research. The company integrates and conducts clinical trials and outcomes research across various therapeutic areas.

Applied Healthcare Research Management Inc. (AHRM)

Pharmaceutical Manufacturing

MedSource (now Ergomed)

PSR Orphan Experts (now Ergomed)

ERGOMED | 43,583 followers on LinkedIn. Bringing expertise to deliver medicines our world can trust. | Ergomed’s fast-growing services business includes an industry-leading suite of specialist pharmacovigilance solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed Clinical Research brand.  The Ergomed group employs over 1,800 people and operates out of 24 offices around the world, providing its services to researchers and patients in around 100 countries globally.

Our Ergomed Clinical Research business was founded in 1997 and provides high-quality clinical research and trial management services globally and across all trial phases (I to IV), specialising in oncology and rare disease trials.

Healthcare Investing @Permira

Silvia Oteri

Florian Kreuzer

Tatiana Lopes

Niek Sluijter

ERGOMED

ERGOMED Group is pleased to welcome Joseph Fleming as Senior Vice President of Strategy and Transformation. With over 25 years of experience in Information Technology, primarily within the pharmaceutical industry, Joe brings a wealth of expertise and leadership. His career journey has seen him excel as a senior developer in pharmacovigilance systems, advance through architecture roles, and eventually lead across various functions in Research and Development. Joe’s extensive background includes Pharmacovigilance, Medical Affairs, Clinical, Regulatory Affairs, Patient Services, Commercial, Supply Chain, and corporate functions. Please join us in welcoming Joseph to the Ergomed team! #Leadership #Strategy #ITTransformation

ERGOMED Clinical Research is gearing up for next week’s CHINATRIALS: Clinical Development Leaders' Summit 16 in Shanghai, China, from November 11-13, 2024! 📍 Visit us at Booth #16 to connect with our expert team and explore how Ergomed offers our innovative clinical research services and custom solutions tailored for the unique needs of your trial. Meet the Team: Dr. Nikola Strumberger , Senior VP, Commercial Operations Lina Svedlund, Director of Business Development & Alliance Management Daorong (Fiona) Zhang, Ergomed Business Development Setup a meeting here: https://lnkd.in/dr53DGTx #ErgomedCRO #ChinaTrials16 #ClinicalResearch #OncologyTrials #RareDiseases #ShanghaiSummit

Looking to advance your Investigational New Drug (IND) expertise? 💻 Join Ergomed experts, Lara Stevanato , PhD, and Melanie Pooler, on November 19th for an exclusive webinar, "Mastering 21 CFR Part 312: Navigating the IND Application Process and Beyond." Dive deep into the IND journey, covering each critical step—from initial submission to ongoing maintenance and safety reporting. 👉 Register now: https://lnkd.in/dbgtwKqW #PharmaRegulations #21CFRPart312 #ClinicalResearch #RegulatoryAffairs

𝑵𝒂𝒗𝒊𝒈𝒂𝒕𝒊𝒏𝒈 𝒕𝒉𝒆 𝑪𝒐𝒎𝒑𝒍𝒆𝒙𝒊𝒕𝒊𝒆𝒔 𝒐𝒇 𝑪𝒍𝒊𝒏𝒊𝒄𝒂𝒍 𝑻𝒓𝒊𝒂𝒍𝒔 𝒊𝒏 𝑹𝒂𝒓𝒆 𝑫𝒊𝒔𝒆𝒂𝒔𝒆𝒔 𝒘𝒊𝒕𝒉 𝑬𝒓𝒈𝒐𝒎𝒆𝒅 In the world of rare diseases, clinical trials present unique challenges for sponsors and CROs. Juliet (Jules) Moritz , Senior Vice President of ERGOMED , sheds light on these ongoing hurdles and how our team is uniquely equipped to address them. 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐦𝐨𝐫𝐞 𝐧𝐨𝐰! 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐡𝐞𝐫𝐞: https://lnkd.in/emdmu6H9 #Ergomed #RareDiseases #ClinicalTrials #CRO #CDMO

Pharma's Almanac

ERGOMED places patients and their care partners’ needs at the core of our services. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients. Connect with our team of experts today: https://lnkd.in/eSqa_JbX Paula Orandash #PatientCentricity #PatientEngagement #ClinicalResearch

It’s about empathy and logistics – ERGOMED balances cutting-edge science with deep respect for patients’ needs in every trial we conduct. Dave Selkirk , President of Ergomed Clinical Research, discusses our patient-centric approach in his conversation with Pharma's Almanac . 👉 Curious for more? Read the full article here: https://lnkd.in/dx_kAfWX #PatientCentric #ClinicalInnovation #PharmaResearch

🌍 November is Lung Cancer Awareness Month! 🌍 Lung cancer remains one of the leading causes of cancer-related deaths worldwide, yet early detection and advances in clinical research are offering new hope. Join ERGOMED in supporting Lung Cancer Awareness Month by advocating for continued research and clinical trials. Together, we can make an impact—one trial, one breakthrough at a time. #LungCancerAwarenessMonth #ErgomedCRO #HealthcareInnovation #CancerResearch #OncologyTrials

Will you be attending #ChinaTrials16 ? We’d love to connect! Visit ERGOMED Clinical Research at Booth #16 to meet our expert team and discover why Ergomed is a leading choice for oncology, rare disease, and complex trials in the U.S. and globally. We offer innovative clinical research services and custom-tailored solutions designed to meet your trial's unique needs. Book a meeting with us today to learn how Ergomed can advance your clinical trials: https://lnkd.in/dr53DGTx #CRO #ClinicalResearch #ChinaTrials16 #Innovation

Me and Nikola Strumberger sending our greetings from Stockholm, BioEurope conference by EBD Group ! Busy as never before I am happy to visit this event, celebrating 30 years now. Don’t hesitate to catch me or Nikola for a chat to discuss how PrimeVigilance or ERGOMED can support in your clinical or post marketing journey. #primevigilance #ergomed #pharmacovigilance #clinical #BIOEurope

Olivija Sileike

ERGOMED Group is thrilled to be attending #BIOEurope 2024 in Stockholm, Sweden, from November 4-6! Join us as Dr. Nikola Strumberger , Senior VP of Commercial Operations of Ergomed Clinical Research, and Olivija Sileike , Director of Business Development at PrimeVigilance , connect with industry leaders, explore groundbreaking innovations, and discuss the evolving future of the life sciences industry. Don’t miss this chance to network, collaborate, and uncover new opportunities in advancing healthcare and life science solutions. Reach out to schedule a meeting with our team! #BIOEurope2024 #ErgomedCRO #LifeSciences

Metric
Company Name	Ergomed Group	Applied Healthcare Research Management Inc. (AHRM)
Symbol
MSH ID	COM:ERGOMEDGROUP	COM:AHRMINC
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Pharmaceuticals	Contract Research Organization (CRO)
Country	GB	US
Stage
Employee Count
Website	ergomedgroup.com	ahrminc.com
LinkedIn	ergomed-clinical-research	applied-healthcare-resource-management
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		1
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

ERGO

COM:ERGOMEDGROUP

Ergomed Group

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue